Quality of life predicts survival in patients with non-small cell lung cancer

BMC Public Health

Research Article

Yih-Dar Lee¹  Chih-Yi Chen²  Te-Chun Hsia³  Cheng-Chieh Lin⁴  Chia-Ing Li⁵  Sing-Yu Yang⁶  Tsai-Chung Li⁷  Chun-Hua Tseng⁸  Kuan-Shin Lin⁸ 

[1] Bristol-Myers Squibb (Taiwan) Ltd, Global Development & Medical Affair, Taipei, Taiwan;Department of Psychiatry, Medical College, National Cheng-Kung University, Tainan, Taiwan;Cancer Center, China Medical University Hospital, Taichung, Taiwan;Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan;Department of Medical Research, China Medical University Hospital, Taichung, Taiwan;School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan;Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan;Department of Medical Research, China Medical University Hospital, Taichung, Taiwan;School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan;Department of Public Health, College of Public Health, China Medical University, Taichung, Taiwan;Graduate Institute of Biostatistics, College of Public Health, China Medical University, Taichung, Taiwan;Graduate Institute of Biostatistics, College of Public Health, China Medical University, Taichung, Taiwan;Department of Healthcare Administration, College of Health Science, Asia University, Taichung, Taiwan;Graduate Institute of Health Care Administration, College of Public Health, China Medical University, Taichung, Taiwan;

关键词: Lung cancer;    HRQOL;    Prognostic factors;    Survival;   

DOI  :  10.1186/1471-2458-12-790

 received in 2011-10-13, accepted in 2012-07-13,  发布年份 2012

来源: Springer

【 摘 要 】

BackgroundPatients with non-small cell lung cancer (NSCLC) have a poor prognosis. The objective of this study was to examine the relationship of EORTC QLQ-C30 and QLQ-LC13 and survival in patients with NSCLC undergoing different treatments.MethodsInvestigators conducted a health-related quality of life (HRQOL) survey of 488 patients with NSCLC: 162 patients undergoing surgery, 312 patients without surgery, and their survival status was prospectively followed up. EORTC QLQ-C30 and QLQ-LC13 scores and clinical variables at baseline were analyzed using Cox’s proportional hazard regression to identify factors that influenced survival.ResultsMedian survival of these 474 patients was 9.82 months. After adjustment, emotional functioning scale, and symptom scales of pain and nausea/vomiting are associated with survival in NSCLC patients with surgery whereas social functioning scale, and symptom scales for fatigue, appetite loss, and financial problems had a significant impact on survival in NSCLC patients without surgery. The results of multivariate analysis showed that none of QLQ-LC13 scales are significant predictors of survival. After simultaneously considering these scales, we found significant independent predictors of survival were nausea/vomiting (HR = 0.11, 95% CI = 0.02-0.63 for score >0 compared with =0) in NSCLC patients with surgery and appetite loss (HR = 1.77, 95% CI = 1.26-2.49 for score >0 compared with =0) in NSCLC patients without surgery.ConclusionsHRQOL provides additional predictive information that supplements traditional clinical factors, and is a new prognostic indicator for survival of NSCLC patients under different treatments.

【 授权许可】

Unknown   
© Li et al.; licensee BioMed Central Ltd. 2012. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.